Melatonin, known for its sleep-inducing properties, and Keppra, an antiepileptic drug, may have a promising coexistence. Recent studies suggest that melatonin could mitigate certain side effects of Keppra, such as insomnia and cognitive impairments. This optimistic finding opens up new possibilities for improved treatment outcomes, enhancing the overall well-being of epilepsy patients.